News

Information about Covid-19

Our priority has always been and always will be the health and safety of our employees as well as those of all our partners (customers, suppliers, territorial communities, etc.).

With the extremely rapid evolution of Covid-19, we actively follow the recommendations of local and global health and government authorities, and we take all necessary measures to protect our teams, in France and in our subsidiaries, while seeking to minimize the risk of disruption to our activities.

SILAB published an overview on the skin microbiome

The microbiome has been a topic of growing interest for both fundamental and applied research especially since it affects health at such various levels.

Gender equality at the heart of SILAB's social policy

On this International Women's Day, SILAB recalls its commitment to professional equality between men and women.

The biotech design of a postbiotic tackling skin dryness

Over the past 10 years, scientists have made enormous progress in the understanding of the role of the microbial flora on health.

Lactobacillus: from probiotics to postbiotics; bioguiding metabolic power of microorganisms

Postbiotics are bioactive metabolites produced by “good bacteria” such as Lactobacillus (i.e. probiotics). In the gut, lactobacillus-produced postbiotics favour the maintenance of the microbiota, improve epithelial cohesion and activate host cells growth.